Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Neurotrope Announces Agreement for Bryostatin-1 with National Cancer Institute

americanpharmaceuticalreviewFebruary 19, 2019

Tag: NCI , Neurotrope , Bryostatin-1 , CD22

PharmaSources Customer Service